Get the Daily Brief
Latest Biotech News
FDA Leadership Shakeup Sends Pharma Stocks Tumbling
Vinay Prasad's abrupt resignation from the FDA's Center for Biologics Evaluation and Research (CBER) has elicited mixed reactions within the biotech sector. Prasad's tenure was marked by...
AI-Powered Advances in Gene Editing and Biomedical Research
Artificial intelligence continues to transform biotechnology with novel tools facilitating gene editing and biomedical analyses. Researchers have developed CRISPR-GPT, an AI system leveraging...
Respiratory Viral Infections Linked to Breast Cancer Metastasis
Groundbreaking research has revealed that common respiratory viruses, including SARS-CoV-2 and influenza, can reactivate dormant breast cancer cells in the lungs, potentially triggering...
Precision Medicine Breakthroughs in Liver and Kidney Disease
Recent studies have identified promising therapeutic strategies addressing liver and kidney pathologies. In liver cancer associated with metabolic dysfunction–associated steatohepatitis...
Large-Scale Venture Funding Signals Biotech Resilience
Despite a challenging funding landscape characterized by reduced overall investment and greater market caution, several leading life sciences venture firms have successfully raised substantial...
Innovative Immunotherapies and Cancer Diagnostic Tools Emerge
Cutting-edge developments in immuno-oncology and cancer diagnostics offer new optimism for patient management. ImmuneOnco and Instil Bio revealed early promising data from a PD-L1xVEGF bispecific...
GLP-1 Receptor Agonists and Obesity-Related Therapeutics Advance
GLP-1 receptor agonists continue to demonstrate efficacy beyond diabetes management. Eli Lilly’s Mounjaro matched older treatments in reducing cardiovascular outcomes and showed promising weight...
Proteomic and Molecular Insights into Neurodegeneration and Aging
Recent cutting-edge studies in neurobiology have yielded significant insights into molecular mechanisms underlying neurodegeneration and brain aging. Killifish models have revealed that...
Sustainable Agriculture and Microbiome Innovations
Agricultural research is advancing through novel initiatives harnessing microbiomes, genetic resources, and innovative pest control technologies. Studies highlight the impact of arbuscular...
Vir Biotechnology’s Strategic Pivot and Sanofi Collaboration in Immuno-Oncology
Following recent commercial and clinical challenges, Vir Biotechnology is aggressively progressing its cancer and infectious disease pipeline. In July 2025, Vir initiated a Phase I trial for...
FDA Leadership Shakeup Amid Sarepta Gene Therapy Controversy
Vinay Prasad abruptly departed his role as Director of the FDA’s Center for Biologics Evaluation and Research after a brief and contentious tenure marked by stringent regulatory decisions,...
Alnylam’s Amvuttra Rare Disease Drug Surges with Expanded Use
Alnylam Pharmaceuticals' Amvuttra, used for hereditary ATTR amyloidosis and a newly approved cardiovascular indication, reported second-quarter revenues reaching $492 million, over double prior...
Advancements in Alzheimer’s Disease Therapeutics and Biomarkers
At the 2025 Alzheimer's Association International Conference, NewAmsterdam Pharma presented data from the Broadway trial highlighting its cholesterol-lowering drug obicetrapib's ability to reduce...
Frazier Life Sciences Secures $1.3B for Early-Stage Biotech Investments
Frazier Life Sciences announced the successful closure of its twelfth venture fund at $1.3 billion, earmarked for early-stage biotechnology startups. The oversubscribed fund boosts its capital...
Medicare Coverage Expansion Boosts Molecular Residual Disease Testing
Saga Diagnostics' Pathlight molecular residual disease (MRD) assay received positive Medicare reimbursement coverage through the MolDx program, allowing surveillance in stage II-III breast cancer...
Breakthroughs in AI-Driven Gene Editing and Artificial Intelligence in Biotech
Cutting-edge AI tools are accelerating the design and application of gene editing technologies. Profluent's OpenCRISPR-1, an AI-generated programmable gene editor, demonstrates superior editing...
Regulatory and Commercial Developments in Pharma and Biotech
The sector witnesses significant commercial realignments and strategic partnerships. Madrigal Pharmaceuticals struck a $2 billion exclusive global license for CSPC Pharmaceutical's preclinical...
Metabolic Surgery and Obesity-Diabetes Mechanisms Uncovered
Metabolic surgery stands among the most effective treatments for obesity and type 2 diabetes, yet its biological mechanisms remain incompletely understood. A recent comprehensive review published...
Novel Diagnostic and Therapeutic Innovations in Ophthalmology
Recent regulatory approvals and clinical advancements are shaping ophthalmic care. Lenz Therapeutics received FDA clearance to launch aceclidine-based eye drops addressing presbyopia, entering a...
Frazier Life Sciences Raises $1.3 Billion for Early-Stage Biotech Investments
Frazier Life Sciences has closed an oversubscribed $1.3 billion venture capital fund to support the creation and early-stage development of innovative biopharmaceutical companies. This marks the...